Argenx to Buy Forte Biosciences for $2.2 Billion
The deal to acquire the Nasdaq-listed Forte represents a 41% premium to its closing price on Friday.
The Source
TWSJ
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Business
Indonesia Central Bank Chief Resigns Unexpectedly
TWSJ·1h ago·3 min read
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Related
On this beat
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Tech
How To Get Your Business Data Ready For AI Agents
FORBES·2h ago·3 min read
Tech
CXMT Chairman Zhu Yiming Amasses $15.9 Billion Fortune By Growing Memory Chip Maker Into Micron Rival
FORBES·2h ago·3 min read